Increased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not ...

Prevail provides superior deliverability, an effective antirestenotic drug formulation (paclitaxel), and sustainable ... to give their patients best-in-class care.” ...

and I believe utilization of this class of technology will continue to grow and evolve over time as the science is expanding. In a field largely reliant on paclitaxel drug-coated balloons, Virtue SAB ...

and I believe utilization of this class of technology will continue to grow and evolve over time as the science is expanding. In a field largely reliant on paclitaxel drug-coated balloons ...

Nearly 40% had diabetes, 17% had renal failure/impairment, and 26% had chronic limb-threatening ischemia (CLTI; Rutherford class ... that paclitaxel DCBs have progressed with each generation and have ...

An ongoing first-in-human phase 1 study (NCT04733027) is currently evaluating the combination of PEP-010 with paclitaxel or gemcitabine in solid tumors. The FDA granted PEP-010, a first-in-class ...